We are live on ! Find out more
AIM

Allen Investment Management Portfolio holdings

AUM $8.43B
1-Year Est. Return 20.31%
This Fund
S&P 500
This Quarter Est. Return
+8.52%
1 Year Est. Return
+20.31%
3 Year Est. Return
+92.36%
5 Year Est. Return
+101.99%
10 Year Est. Return
+554.07%
AUM
$5.89B
AUM Growth
+$509M
Cap. Flow
+$135M
Cap. Flow %
2.29%
Top 10 Hldgs %
54.65%
Holding
193
New
14
Increased
50
Reduced
54
Closed
7

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$90.8M
2
SCHW
Charles Schwab
SCHW
+$46.9M
3
NOC icon
Northrop Grumman
NOC
+$42.6M
4
BABA icon
Alibaba
BABA
+$41M
5
SYY icon
Sysco
SYY
+$18.6M

Top Sells

Rank Stock Value
1
TDG icon
TransDigm Group
TDG
+$160M
2
LH icon
Labcorp
LH
+$5.45M
3
TWLO icon
Twilio
TWLO
+$4.65M
4
BKNG icon
Booking.com
BKNG
+$4.36M
5
W icon
Wayfair
W
+$4.24M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 25.99%
2 Communication Services 24.48%
3 Financials 13.4%
4 Healthcare 10.75%
5 Technology 10.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AYI icon
101
Acuity Brands
AYI
$10.7B
$1.27M 0.02%
+10,530
New +$1.13M
AVGO icon
102
Broadcom
AVGO
$1.98T
$1.27M 0.02%
29,020
+5,160
+22% +$201K
ALCO icon
103
Alico
ALCO
$307M
$1.25M 0.02%
40,391
VOO icon
104
Vanguard S&P 500 ETF
VOO
$1.03T
$1.09M 0.02%
3,176
IWV icon
105
iShares Russell 3000 ETF
IWV
$20.4B
$1.07M 0.02%
4,807
OEF icon
106
iShares S&P 100 ETF
OEF
$20.4B
$1.03M 0.02%
6,028
MRK icon
107
Merck
MRK
$322B
$1.03M 0.02%
13,208
-712
-5% -$54.5K
ABBV icon
108
AbbVie
ABBV
$442B
$1.02M 0.02%
9,489
+846
+10% +$81.3K
TME icon
109
Tencent Music
TME
$14.3B
$980K 0.02%
50,953
DOV icon
110
Dover
DOV
$28.1B
$978K 0.02%
7,743
-201
-3% -$23.9K
NVDA icon
111
NVIDIA
NVDA
$5.27T
$942K 0.02%
72,160
+1,240
+2% +$16.6K
MCD icon
112
McDonald's
MCD
$194B
$931K 0.02%
4,337
-442
-9% -$96.1K
BLK icon
113
Blackrock
BLK
$178B
$924K 0.02%
1,280
-115
-8% -$76.3K
UL icon
114
Unilever
UL
$134B
$918K 0.02%
13,513
+9,186
+212% +$623K
DCI icon
115
Donaldson
DCI
$11.2B
$894K 0.02%
16,000
HD icon
116
Home Depot
HD
$353B
$879K 0.01%
3,308
+14
+0.4% +$3.85K
VEU icon
117
Vanguard FTSE All-World ex-US ETF
VEU
$70B
$814K 0.01%
13,952
TSM icon
118
TSMC
TSM
$2.19T
$774K 0.01%
7,101
DIS icon
119
Walt Disney
DIS
$179B
$765K 0.01%
4,225
+169
+4% +$24.3K
PFE icon
120
Pfizer
PFE
$152B
$734K 0.01%
19,936
+47
+0.2% +$1.72K
IWF icon
121
iShares Russell 1000 Growth ETF
IWF
$127B
$644K 0.01%
10,684
HON icon
122
Honeywell
HON
$72.9B
$640K 0.01%
3,195
-364
-10% -$66.1K
LMT icon
123
Lockheed Martin
LMT
$138B
$611K 0.01%
1,720
+21
+1% +$7.72K
IWP icon
124
iShares Russell Mid-Cap Growth ETF
IWP
$20.8B
$606K 0.01%
5,908
-30
-0.5% -$2.85K
INTC icon
125
Intel
INTC
$493B
$604K 0.01%
12,127
-955
-7% -$46.6K

Similar funds

Allen Investment Management's Q4 2020 Portfolio in Review

As of Q4 2020, Allen Investment Management held 193 positions worth $5.89B, up 9.5% from $5.38B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Allen Investment Management's Q4 2020 filing shows 14 new, 50 increased, 54 reduced and 7 closed positions. Its largest new stake was People Inc: 17,004 shares worth $1.76M. The largest sale was TransDigm Group, an estimated $160M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 26% of assets, down from 29% a quarter earlier, followed by Communication Services and Financials.

  • Allen Investment Management's largest Q4 2020 buy was People Inc: 17,004 shares worth $1.76M.
  • Allen Investment Management added most to Visa in Q4 2020, an estimated $90.8M increase.
  • Allen Investment Management's biggest Q4 2020 reduction was TransDigm Group, cutting an estimated $160M.
  • Allen Investment Management fully exited Activision Blizzard in Q4 2020, selling an estimated $3.29M.
  • Allen Investment Management's ten largest holdings make up 55% of its $5.89B portfolio in Q4 2020.
  • Allen Investment Management opened 14 new positions and closed 7 in Q4 2020.
  • Allen Investment Management's portfolio value rose 9.5% quarter-over-quarter to $5.89B.

Based on Allen Investment Management's 13F filing for Q4 2020, filed 3 Feb 2021.